Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
5,872,301
-
Share change
-
+601,692
-
Total reported value
-
$167,046,670
-
Put/Call ratio
-
68%
-
Price per share
-
$28.45
-
Number of holders
-
41
-
Value change
-
+$17,699,694
-
Number of buys
-
20
-
Number of sells
-
17
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q3 2017
As of 30 Sep 2017,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,872,301 shares.
The largest 10 holders included
FMR LLC, FARALLON CAPITAL MANAGEMENT LLC, SPHERA FUNDS MANAGEMENT LTD., Tekla Capital Management LLC, LAZARD ASSET MANAGEMENT LLC, MORGAN STANLEY, CREDIT SUISSE AG/, Abingworth LLP, Artal Group S.A., and Balyasny Asset Management LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.